Chronic HCV infection†‐ interferon‐alpha versus no intervention · people with acute hepatitis C infection
It is very uncertain whether intervention changes chronic HCV infection†‐ interferon‐alpha versus no intervention compared with no intervention or control intervention (control) (very low certainty).
1 finding from 1 review
Chronic HCV infection†‐ interferon‐beta versus no intervention · people with acute hepatitis C infection
It is very uncertain whether intervention changes chronic HCV infection†‐ interferon‐beta versus no intervention compared with no intervention or control intervention (control) (very low certainty).
1 finding from 1 review
Chronic HCV infection†‐ MTH‐68/B vaccine versus no intervention · people with acute hepatitis C infection
It is very uncertain whether intervention changes chronic HCV infection†‐ MTH‐68/B vaccine versus no intervention compared with no intervention or control intervention (control) (very low certainty).
1 finding from 1 review
Adverse events (proportion) ‐ interferon‐alpha versus no intervention · people with acute hepatitis C infection
It is very uncertain whether intervention changes adverse events (proportion) ‐ interferon‐alpha versus no intervention compared with no intervention or control intervention (control) (very low certainty).
1 finding from 1 review
Adverse events (number) ‐ interferon‐beta versus no intervention · people with acute hepatitis C infection
It is very uncertain whether intervention changes adverse events (proportion) ‐ interferon‐beta versus no intervention compared with no intervention or control intervention (control) (very low certainty).
2 findings from 1 review
Slippages (over the intervention period) · infants
Skin care intervention showed no clear difference in slippages (over the intervention period) compared with standard skin care or no skin care intervention (low certainty).
1 finding from 1 review
Skin infection (over the intervention period) · infants
Skin care intervention probably leads to higher skin infection (over the intervention period) compared with standard skin care or no skin care intervention (moderate certainty).
1 finding from 1 review
Stinging/allergic reactions to moisturisers (over the intervention period) · infants
Skin care intervention showed no clear difference in stinging/allergic reactions to moisturisers (over the intervention… compared with standard skin care or no skin care intervention (low certainty).
1 finding from 1 review
Body‐mass index (BMI) · employees
1 finding from 1 review
Systolic blood pressure · employees
1 finding from 1 review
LDL‐cholesterol · employees
1 finding from 1 review
LDL‐cholesterol · employees
1 finding from 1 review
Burnout · health and social professionals
1 finding from 1 review
Blood lead levels (continuous)Blood lead level at end of duration Scale: 0–30 · children (aged 0–2 years)
1 finding from 1 review
Dysarthria intervention versus any control for stroke subgroup: persisting effects, activity level · adults with dysarthria following stroke or other adult‐acquired, non‐progressive brain injury
2 findings from 1 review
Dysarthria intervention versus any control: persisting effects, impairment level · adults with dysarthria following stroke or other adult‐acquired, non‐progressive brain injury
1 finding from 1 review
Participation · adults with dysarthria following stroke or other adult‐acquired, non‐progressive brain injury
1 finding from 1 review
Dysarthria intervention versus any control: immediate effects, activity level · adults with dysarthria following stroke or other adult‐acquired, non‐progressive brain injury
1 finding from 1 review
Dysarthria intervention versus any control: immediate effects, impairment level · adults with dysarthria following stroke or other adult‐acquired, non‐progressive brain injury
1 finding from 1 review
Serious adverse events (number) ‐ pegylated interferon‐alpha plus ribavirin versus pegylated interferon‐alpha · people with acute hepatitis C infection
It is very uncertain whether intervention changes serious adverse events (proportion) ‐ pegylated interferon‐alpha… compared with no intervention or control intervention (control) (very low certainty).
2 findings from 1 review
OR 1.72 [0.7, 4.21]
2 studies · 237 participants
Very low
Rate ratio 2.74 [1.4, 5.33]
2 studies · 237 participants
Very low